People's Hospital of Anshun City of Guizhou Province
7
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
0.0%
-86.5% vs industry average
29%
2 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Application and Demonstration of Endoscope-assisted Low-temperature Plasma Radiofrequency Ablation Resection of Tonsils
Role: lead
Evaluation of Two Different Treatments for Lower Pore Renal Stone: Microperc Vs FURS
Role: collaborator
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
Role: lead
Multicenter Study of Impulse Oscillometry in Chinese
Role: collaborator
Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides
Role: collaborator
Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis
Role: collaborator
All 7 trials loaded